Disrupting Study Start-Up

In the midst of scientific breakthroughs, new therapies can still take up to 15 years to reach your medicine cabinet. This figure has not improved in the last 15–20 years. This is simply unacceptable. We need to do better.

Why is that? We all know there are many challenges and bottlenecks in clinical trials from patient recruitment and retention, to lack of efficacy and safety, to reimbursement and affordability to the patient. What we really don’t hear about as often is how the process of study start-up and delivering trials through enabling eClinical technology can by itself accelerate the clinical trial timeline.

If each system had a few days delay because of UAT (user acceptance testing) findings including defects and quality issues, across six systems, the overall delays can be quite costly.